Tassone F - Search Results

1

Diabetes and Bone Involvement in Primary Hyperparathyroidism: Literature Review and Our Personal Experience.

Castellano E, Attanasio R, Boriano A, Borretta V, Tassone F, Borretta G. Castellano E, et al. Among authors: tassone f. Front Endocrinol (Lausanne). 2021 Apr 19;12:665984. doi: 10.3389/fendo.2021.665984. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33953702 Free PMC article. Review.

2

[Renal function in primary hyperparathyroidism].

Borretta G, Gianotti L, Cesario F, Borretta V, Tassone F. Borretta G, et al. Among authors: tassone f. G Ital Nefrol. 2010 Sep-Oct;27 Suppl 50:S91-5. G Ital Nefrol. 2010. PMID: 20922703 Italian.

3

Vitamin D status in primary hyperparathyroidism: a Southern European perspective.

Tassone F, Gianotti L, Baffoni C, Visconti G, Pellegrino M, Cassibba S, Croce CG, Magro G, Cesario F, Attanasio R, Borretta G. Tassone F, et al. Clin Endocrinol (Oxf). 2013 Dec;79(6):784-90. doi: 10.1111/cen.12210. Epub 2013 Apr 17. Clin Endocrinol (Oxf). 2013. PMID: 23521111

4

Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism.

Gianotti L, Tassone F, Baffoni C, Pellegrino M, Cassibba S, Castellano E, Magro G, Cesario F, Visconti G, Borretta G. Gianotti L, et al. Among authors: tassone f. Clin Endocrinol (Oxf). 2014 Sep;81(3):350-5. doi: 10.1111/cen.12472. Epub 2014 May 19. Clin Endocrinol (Oxf). 2014. PMID: 24750210

5

Parathyroidectomy Halts the Deterioration of Renal Function in Primary Hyperparathyroidism.

Tassone F, Guarnieri A, Castellano E, Baffoni C, Attanasio R, Borretta G. Tassone F, et al. J Clin Endocrinol Metab. 2015 Aug;100(8):3069-73. doi: 10.1210/jc.2015-2132. Epub 2015 Jun 16. J Clin Endocrinol Metab. 2015. PMID: 26079781

6

Forearm DXA Increases the Rate of Patients With Asymptomatic Primary Hyperparathyroidism Meeting Surgical Criteria.

Castellano E, Attanasio R, Gianotti L, Cesario F, Tassone F, Borretta G. Castellano E, et al. Among authors: tassone f. J Clin Endocrinol Metab. 2016 Jul;101(7):2728-32. doi: 10.1210/jc.2016-1513. Epub 2016 Apr 12. J Clin Endocrinol Metab. 2016. PMID: 27070376

7

Mild primary hyperparathyroidism as defined in the Italian Society of Endocrinology's Consensus Statement: prevalence and clinical features.

Castellano E, Tassone F, Attanasio R, Gianotti L, Pellegrino M, Borretta G. Castellano E, et al. Among authors: tassone f. J Endocrinol Invest. 2016 Mar;39(3):349-54. doi: 10.1007/s40618-015-0412-6. Epub 2015 Nov 30. J Endocrinol Invest. 2016. PMID: 26620949

8

A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism.

Gianotti L, Tassone F, Cesario F, Pia A, Razzore P, Magro G, Piovesan A, Borretta G. Gianotti L, et al. Among authors: tassone f. J Clin Endocrinol Metab. 2006 Aug;91(8):3011-6. doi: 10.1210/jc.2006-0070. Epub 2006 May 30. J Clin Endocrinol Metab. 2006. PMID: 16735490

9

May an altered hypothalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism?

Gianotti L, Tassone F, Pia A, Bovio S, Reimondo G, Visconti G, Terzolo M, Borretta G. Gianotti L, et al. Among authors: tassone f. Calcif Tissue Int. 2009 Jun;84(6):425-9. doi: 10.1007/s00223-009-9245-7. Epub 2009 Apr 19. Calcif Tissue Int. 2009. PMID: 19381429

10

Silent renal stones in primary hyperparathyroidism: prevalence and clinical features.

Cassibba S, Pellegrino M, Gianotti L, Baffoni C, Baralis E, Attanasio R, Guarnieri A, Borretta G, Tassone F. Cassibba S, et al. Among authors: tassone f. Endocr Pract. 2014 Nov;20(11):1137-42. doi: 10.4158/EP14074.OR. Endocr Pract. 2014. PMID: 24936557

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters